Compile Data Set for Download or QSAR
maximum 50k data
Found 30 Enz. Inhib. hit(s) with all data for entry = 7060
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171378(US9085571, Table 1, Compound 26)
Affinity DataKi:  0.100nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171372(US9085571, Table 1, Compound 20)
Affinity DataKi:  0.200nM IC50:  30nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171370(US9085571, Table 1, Compound 18)
Affinity DataKi:  0.300nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171354(US9085571, Table 1, Compound 2)
Affinity DataKi:  0.600nM IC50:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171371(US9085571, Table 1, Compound 19)
Affinity DataKi:  0.600nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171353(US9085571, Table 1, Compound 1)
Affinity DataKi:  0.600nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171374(US9085571, Table 1, Compound 22)
Affinity DataKi:  1nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171380(US9085571, Table 1, Compound 28)
Affinity DataKi:  2nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171382(US9085571, Table 1, Compound 30)
Affinity DataKi:  4.01nM IC50:  32nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171365(US9085571, Table 1, Compound 13)
Affinity DataKi:  5nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171375(US9085571, Table 1, Compound 23)
Affinity DataKi:  5nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171373(US9085571, Table 1, Compound 21)
Affinity DataKi:  6nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171357(US9085571, Table 1, Compound 5)
Affinity DataKi:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171367(US9085571, Table 1, Compound 15)
Affinity DataKi:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171369(US9085571, Table 1, Compound 17)
Affinity DataKi:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171381(US9085571, Table 1, Compound 29)
Affinity DataKi:  30nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171363(US9085571, Table 1, Compound 11)
Affinity DataKi:  40nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171364(US9085571, Table 1, Compound 12)
Affinity DataKi:  50nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171376(US9085571, Table 1, Compound 24)
Affinity DataKi:  70nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171377(US9085571, Table 1, Compound 25)
Affinity DataKi:  100nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171366(US9085571, Table 1, Compound 14)
Affinity DataKi:  100nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171368(US9085571, Table 1, Compound 16)
Affinity DataKi:  200nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171362(US9085571, Table 1, Compound 10)
Affinity DataKi:  200nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171361(US9085571, Table 1, Compound 9)
Affinity DataKi:  200nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171360(US9085571, Table 1, Compound 8)
Affinity DataKi:  300nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171355(US9085571, Table 1, Compound 3)
Affinity DataKi:  300nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171356(US9085571, Table 1, Compound 4)
Affinity DataKi:  400nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171379(US9085571, Table 1, Compound 27)
Affinity DataKi:  600nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171358(US9085571, Table 1, Compound 6)
Affinity DataKi:  1.00E+3nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtease(Human immunodeficiency virus 1 (HIV-1))
Purdue Research Foundation

US Patent
LigandPNGBDBM171359(US9085571, Table 1, Compound 7)
Affinity DataKi:  1.00E+3nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In DepthDetails US Patent